glioma

The researchers believe using cerebral spinal fluid will enable them to identify brain tumors with a higher sensitivity than with blood samples.

The researchers aim to offer the half-hour diagnostic assay for use during neurosurgery to help clinicians pursue the best treatment for patients with gliomas.  

The researchers said that their deep-learning interpreter of outcomes for patients with gliomas could be more accurate and objective than pathologists.